Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
NIKKEI 225
38,946.93
-122.75
(-0.31%)
HANG SENG
19,198.34
-437.88
(-2.23%)
CRUDE OIL
79.29
-0.51
(-0.64%)
GOLD FUTURES
2,419.50
-19.00
(-0.78%)
DOW
39,806.77
-196.82
(-0.49%)
Bitcoin GBP
56,083.18
+3,458.55
(+6.57%)
Stocks
Trending tickers: Gold, Ryanair, Nvidia and AstraZeneca
The latest investor updates on stocks that are trending on Monday
Caribou Biosciences, Inc. (CRBU)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1300
-0.2600
(-7.67%)
At close: 04:00PM EDT
3.1300
0.00
(0.00%)
After hours:
07:39PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
33,404
34,477
13,851
9,598
12,361
Operating expenses
Research development
120,154
112,075
82,230
52,255
34,425
Selling general and administrative
44,195
38,461
38,020
24,322
14,060
Total operating expenses
164,349
150,536
120,250
76,577
48,485
Operating income or loss
-130,945
-116,059
-106,399
-66,979
-36,124
Interest expense
-
-
-
8
20
Total other income/expenses net
15,878
14,182
7,048
377
-219
Income before tax
-115,067
-101,877
-99,351
-66,602
-36,127
Income tax expense
-
193
70
321
-1,819
Income from continuing operations
-115,260
-102,070
-99,421
-66,923
-34,308
Net income
-115,260
-102,070
-99,421
-66,923
-34,308
Net income available to common shareholders
-115,260
-102,070
-99,421
-66,923
-34,308
Basic EPS
-1.43
-
-1.64
-2.11
-1.24
Diluted EPS
-1.43
-
-1.64
-2.11
-1.24
Basic average shares
66,912
-
60,801
31,663
27,657
Diluted average shares
66,912
-
60,801
31,663
27,657
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.